Browse All
Displaying 1066 - 1070 of 1714
Author:Cohen, Jeffrey Hauser, Stephen Cross, Anne Winthrop, Kevin Wiendl, Heinz Nicholas, Jacqueline Meuth, Sven Giacomini, Paul Sacca, Francesco Zielman, Ronald Das Gupta, Ayan Hu, Xixi Sullivan, Roseanne DeLasHeras, Virginia Kappos, Ludwig
Session Name:P8: MS Therapeutics 2
Topic:MS and Inflammatory Disease
Program Number:P8.004
Author Institution:Department of Neurology, Mellen MS Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA, Cleveland, OH UCSF Weill Institute for Neurosciences, University of California, San Francisco, CA, USA, San Francisco, CA Washington University School of Medicine, Saint Louis, MO, USA, Clayton, MO Public Health and Preventive Medicine, Division of Infectious Diseases, Oregon Health and Sciences University, Portland, OR, USA, Portland, OR University of Muenster, Muenster, Germany, Muenster, Germany OhioHealth Multiple Sclerosis Center, Columbus, OH, USA, Columbus, OH Department of Neurology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany, Duesseldorf, Germany Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada, Montreal, QC, Canada NSRO Department, University “Federico II” of Naples, Naples, Italy, Napoli, Italy Novartis Pharma B.V., Amsterdam, The Netherlands, Haaksbergweg, Netherlands Novartis Healthcare Pvt. Ltd., Hyderabad, India, Hyderabad, India Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, Morristown, NJ Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, East Hanover, NJ Novartis Pharma AG, Basel, Switzerland, Basel, Switzerland Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) and MS Center, Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, Basel, Switzerland
Author:Jandhyala, Nora Garcia, Mekka Kim, Monica Segal, Devorah Yohay, Kaleb
Session Name:P8: Neuro-oncology: Cancer Predisposition Syndromes
Topic:Neuro-oncology
Author Institution:NYU Grossman School of Medicine, New York, NY NYU Langone Health, New York, NY Nationwide Children’s Hospital, Columbus, OH
Author:Sekiya, Hiroaki Koga, Shunsuke Ross, Owen Dickson, Dennis
Session Name:P8: Movement Disorders: Atypical Parkinsonisms 1
Topic:Movement Disorders
Author Institution:Mayo Clinic, Jacksonville, FL
Author:Berry, James Maragakis, Nicholas Paganoni, Sabrina Quintana, Melanie Macklin, Eric Saville, Benjamin Andrews, Jinsy Shefner, Jeremy Detry, Michelle Menon, Parvathi Huynh, William Mahoney, Colin Stommel, Elijah Hall, Meghan Connolly, Mariah Kittle, Gale Chase, Marianne Sherman, Alexander Yu, Hong Pothier, Lindsay Drake, Kristin Chibnik, Lori Bind, Marie-Abele Vestrucci, Matteo Glanzman, Robert Hotchkin, Michael Vucic, Steve Kiernan, Matthew Cudkowicz, Merit Study Group, HEALEY ALS Platform Trial Investigators, RESCUE-ALS
Session Name:P8: Neuromuscular Disease: Amyotrophic Lateral Sclerosis 1
Topic:Neuromuscular and Clinical Neurophysiology (EMG)
Author Institution:Massachusetts General Hospital, Boston, MA Johns Hopkins University School of Medicine, Baltimore, MD Berry Consultants, San Francisco, CA MGH Biostatistics Center, Boston, MA Columbia University Medical Center, New York, NY Barrow Neurological Institute, Phoenix, AZ Westmead Public Hospital, Sydney, Australia Prince of Wales Hospital, Randwick, Australia University of Sydney, Sydney, Australia Dartmouth-Hitchock Med Ctr/Dept of Neuro, Lebanon, NH Massachusetts General Hospital, Charlestown, MA Clene Nanomedicine Inc, Holladay, UT Clene Nanomedicine, Inc., Salt Lake City, UT Brain and Mind Centre, Sydney, Australia HEALEY ALS Platform Trial, Boston, MA RESCUE-ALS Trial, Sydney, Australia
Author:Kamali, Tahereh Day, John Sampson, Jacinda Murad, Alejandro Chaufty, Jeremy
Session Name:P8: General Neurology: Neuroimaging
Topic:General Neurology
Author Institution:Stanford University School of Medicine, Palo Alto, CA UCB Biopharma, Boston, MA
